Overview
AMH (anti Mullerian hormone) is a monitor of ovarian reserve function. Compared with traditional indicators, it is not affected by the regular changes of menstrual cycle, and can be checked by blood sampling at any time during the menstrual cycle.
Relying on the scientific research strength of Xiamen University, Wantai biology has broken the international patent barrier, developed AMH antibody with independent intellectual property rights, and achieved self-produced core bioactive materials and controllable test batch to batch. The upper limit of detection is 25ng/ml, helping to evaluate the ovarian function status and early screening, diagnosis and treatment of related diseases.
Independent research and development
Breaking through patent barriers
Self production of core bioactive materials
High sensitivity
High accuracy
Product Advantages
Breaking patent barriers
Wantai BioPharm and Xiamen University jointly broke through international technical barriers, developed AMH antibody with independent intellectual property rights, and realized the localization of core diagnostic technology.
Self production of core bioactive materials
Wantai BioPharm independently produces the core bioactive materials of detection tests to ensure the stability of the supply chain, not affected by international market fluctuations, while effectively controlling costs and providing a stable guarantee for clinical detection.
Inter batch differences are controllable
Through independent production of core bioactive materials and strict quality control system, the differences between product batches can be controlled, ensuring the stability and consistency of test results, and providing a reliable basis for clinical practice.
High detection upper limit
The upper limit of detection is 25ng/ml, which is significantly higher than that of similar products. It can meet the detection needs of various clinical situations, especially for the detection of diseases with increased AMH levels such as polycystic ovary syndrome.
Clinical Application
AMH testing has a wide range of applications in the field of female reproductive health, providing important reference for various clinical situations.
Assessment of Ovarian Reserve Function
Precisely assess the status of a woman's ovarian reserve function, providing a scientific reference for female fertility planning; determine the conditions of ovarian insufficiency or functional decline; predict the time of menopause.
Predicting Ovarian Reactivity in Assisted Reproduction
Evaluate the baseline ovarian reserve capacity, predict the ovarian reactivity to ovulation-stimulating drugs, and optimize the selection of treatment plans.
Auxiliary Diagnosis of Polycystic Ovary Syndrome
Studies have shown that compared with healthy people of the same age, the serum AMH index of patients with polycystic ovary syndrome is 2 to 3 times higher, which can be used as one of the auxiliary diagnostic indicators for this disease.
Monitoring of Fertility in Cancer Patients before and after Treatment
For female cancer patients of childbearing age who need to preserve their fertility, compared with the menstrual status, AMH can be more accurately used to evaluate the ovarian reserve function of patients before and after treatment.
For more information : wtexport@ystwt.com
Filing Number:(京)网药械信息备字（2025）第 00190 号
Copyright©Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
|
|
京公网安备11011402010353号 
Alibaba Cloud provides cloud computing and security services.|
It supports
|
Powered by CloudDream
|
Terms Of Use|
Privacy Statement